Study Description
This is a multicenter, non-randomized, non-interventional cohort study with prospective
and retrospective collection of primary data on heart failure with reduced ejection
fraction (HFrEF) patient treatment and care following a decompensation event in different
types of Heart Failure Unit (HFU) or non-HFU centers across Germany. This study aims to describe quality of care of HFrEF patients following a decompensation
event in different center types (=settings) utilizing the quality indicators for the care
and outcomes of adults with heart failure as specified by the Heart Failure Association
in 2022.
No strict visit schedule will be imposed on participants to avoid interference with
routine clinical care. HFrEF patients will be treated according to the local routine in
terms of medication, visit frequency and types of assessments performed and only these
data will be collected as part of the study from patient files.
Interventions
Heart Failure medications
Eligibility Criteria
Inclusion Criteria:
1. Patients who provide written informed consent to participate in the study
2. Male or female patients ≥ 18 years of age
3. Patients with diagnosis of heart failure with reduced ejection fraction (HFrEF) and
HF treatment according to the summaries of product characteristics (SmPCs)
4. Decompensation event up to three months prior to inclusion
Exclusion Criteria:
1. Simultaneous or planned participation in an interventional research study
2. Participation in this study at another site e.g. in a HFU network
3. Patients incapable of understanding and signing the informed consent form
Worldwide Contacts
If the location of your choosing does not feature any contact detail, please reach out using the information below.